Home » Topics » BioWorld Science, Cancer

BioWorld Science, Cancer
RSS

Survival benefit seen in patients with brain tumors or metastases on RSR-13 plus cranial RT

May 26, 2000

Early phase II results justify further development of CT-2584 in patients with sarcomas

May 26, 2000

Phase I data presented at ASCO for L-377202, a peptide conjugate of doxorubicin

May 25, 2000

ASCO news: polymeric CPT derivative assessed in phase I for toxicity and pharmacokinetics

May 25, 2000

Lipophilic camptothecin derivatives with favorable profile of activity, toxicity

May 25, 2000

AstraZeneca develops new treatments for cancer, rheumatoid arthritis, etc.

May 25, 2000

Oregon State U. researchers disclose curacin A derivatives with improved stability

May 25, 2000

TNP-470 delays gastric ulcer healing in rats

May 25, 2000

GTI-2040 phase I/II trial on target for completion by year-end

May 25, 2000

Proteasome inhibitor MG-132 endowed with antineoplastic activity

May 25, 2000

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 17, 2026.
Celia trial: data strong, analysts skeptical
BioWorld
Tuesday brought what was arguably the most anticipated presentation of the 2026 Alzheimer’s Association International Conference when Catherine Mummery, head of...
News in brief
BioWorld Asia
BioWorld Asia briefs for July 14, 2026
Voyager’s gene therapy reduces tau levels in AD models
BioWorld Science
At the Alzheimer’s Association International Conference, researchers from Voyager Therapeutics Inc. presented preclinical efficacy data for VY-1706, a blood-brain...
GABA signaling linked to immune resistance in some tumors
BioWorld
Certain cancers that contain organized clusters of immune cells known as tertiary lymphoid structures (TLS) do not respond to treatment as well as expected. Even...